Literature DB >> 21886897

Molecular modeling on structure-function analysis of human progesterone receptor modulators.

Ria Pal1, Md Ataul Islam, Tabassum Hossain, Achintya Saha.   

Abstract

Considering the significance of progesterone receptor (n class="Gene">PR) modulators, the present study is explored to envisage the biophoric signals for binding to selective PR subtype-A using ligand-based quantitative structure activity relationship (QSAR) and pharmacophore space modeling studies on nonsteroidal substituted quinoline and cyclocymopol monomethyl ether derivatives. Consensus QSAR models (Training set (Tr): n(Tr)=100, R(2) (pred)=0.702; test set (Ts): n(Ts)=30, R(2) (pred)=0.705, R(2) (m)=0.635; validation set (Vs): n(Vs)=40, R(2) (pred)=0.715, R(2) (m)=0.680) suggest that molecular topology, atomic polarizability and electronegativity, atomic mass and van der Waals volume of the ligands have influence on the presence of functional atoms (F, Cl, N and O) and consequently contribute significant relations on ligand binding affinity. Receptor independent space modeling study (Tr: n(Tr)=26, Q(2)=0.927; Ts: n(Ts)=60, R(2) (pred)=0.613, R(2) (m)=0.545; Vs: n(Vs)=84, R(2) (pred)=0.611, R(2) (m)=0.507) indicates the importance of aromatic ring, hydrogen bond donor, molecular hydrophobicity and steric influence for receptor binding. The structure-function characterization is adjudged with the receptor-based docking study, explaining the significance of the mapped molecular attributes for ligand-receptor interaction in the catalytic cleft of PR-A.

Entities:  

Keywords:  Binding affinity; Docking; Human progesterone receptor-A; Pharmacophore mapping; QSAR; Quinoline and cyclocymopol monomethyl ether derivatives

Year:  2011        PMID: 21886897      PMCID: PMC3163366          DOI: 10.3797/scipharm.1105-03

Source DB:  PubMed          Journal:  Sci Pharm        ISSN: 0036-8709


  31 in total

1.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

Review 2.  Molecular recognition and docking algorithms.

Authors:  Natasja Brooijmans; Irwin D Kuntz
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-01-28

Review 3.  Development of quantitative structure-activity relationships and its application in rational drug design.

Authors:  Guang-Fu Yang; Xiaoqin Huang
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions.

Authors:  A K Ghose; G M Crippen
Journal:  J Chem Inf Comput Sci       Date:  1987-02

5.  5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.

Authors:  L Zhi; C M Tegley; K B Marschke; D E Mais; T K Jones
Journal:  J Med Chem       Date:  1999-04-22       Impact factor: 7.446

6.  Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands.

Authors:  Annu A Söderholm; Pekka T Lehtovuori; Tommi H Nyrönen
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

7.  Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists.

Authors:  David G Jones; Xi Liang; Eugene L Stewart; Robert A Noe; Lara S Kallander; Kevin P Madauss; Shawn P Williams; Scott K Thompson; David W Gray; William J Hoekstra
Journal:  Bioorg Med Chem Lett       Date:  2005-07-01       Impact factor: 2.823

8.  A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.

Authors:  Kevin P Madauss; Eugene T Grygielko; Su-Jun Deng; Anthony C Sulpizio; Thomas B Stanley; Charlene Wu; Steve A Short; Scott K Thompson; Eugene L Stewart; Nicholas J Laping; Shawn P Williams; Jeffrey D Bray
Journal:  Mol Endocrinol       Date:  2007-03-13

9.  Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.

Authors:  Yongli Du; Qunyi Li; Bing Xiong; Xin Hui; Xin Wang; Yang Feng; Tao Meng; Dingyu Hu; Datong Zhang; Mingwei Wang; Jingkang Shen
Journal:  Bioorg Med Chem       Date:  2010-05-24       Impact factor: 3.641

10.  5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.

Authors:  C M Tegley; L Zhi; K B Marschke; M M Gottardis; Q Yang; T K Jones
Journal:  J Med Chem       Date:  1998-10-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.